Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin A Dean

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|March 6, 2023
Repeatability of metabolic tumor burden and lesion glycolysis between clinical readersJung W Choi, Erin A Dean, Hong Lu, et al.
Ejhaem|July 25, 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to TransplantErin A Dean, Rick Y Lin, Tuo Lin, et al.
Frontiers in Oncology|September 25, 2025
Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myelomaErin A Dean, Derek M Li, Tuo Lin, et al.
The American Journal of Case Reports|September 3, 2020
Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose AdriamycinThanh-Phuong N Afiat, Timothy N Hembree, Erin A Dean, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Leukemia & Lymphoma|June 6, 2024
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemiaKriti Gera, Christina Cline, Zeina Al-Mansour, et al.
Blood Advances|July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Rahul S Mhaskar, Hong Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2025
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute LeukemiaJohn R Wingard, Ji-Hyun Lee, Derek Li, et al.
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|March 6, 2023
Repeatability of metabolic tumor burden and lesion glycolysis between clinical readersJung W Choi, Erin A Dean, Hong Lu, et al.
Ejhaem|July 25, 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to TransplantErin A Dean, Rick Y Lin, Tuo Lin, et al.
Frontiers in Oncology|September 25, 2025
Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myelomaErin A Dean, Derek M Li, Tuo Lin, et al.
The American Journal of Case Reports|September 3, 2020
Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose AdriamycinThanh-Phuong N Afiat, Timothy N Hembree, Erin A Dean, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Leukemia & Lymphoma|June 6, 2024
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemiaKriti Gera, Christina Cline, Zeina Al-Mansour, et al.
Blood Advances|July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Rahul S Mhaskar, Hong Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2025
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute LeukemiaJohn R Wingard, Ji-Hyun Lee, Derek Li, et al.
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Pageof 3